1,243
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Cardioprotective activity of standardized extract of Ficus racemosa stem bark against doxorubicin-induced toxicity

&
Pages 468-473 | Received 28 Mar 2011, Accepted 09 Aug 2011, Published online: 02 Dec 2011

References

  • Ahmed F, Urooj A. (2009a). Antioxidant activity of various extracts of Ficus racemosa stem bark. Nat J Life Sci, 6, 69–74.
  • Ahmed F, Urooj A. (2009b). Glucose lowering, hepatoprotective and hypolipidemic activity of stem bark of Ficus racemosa in streptozotocin-induced diabetic rats. J Young Pharm, 1, 160–164.
  • Ahmed F, Urooj A. (2010). Hepatoprotective effects of Ficus racemosa stem bark against carbon tetrachloride-induced hepatic damage in albino rats. Pharm Biol, 48, 210–216.
  • Billingham ME, Mason JW, Bristow MR, Daniels JR. (1978). Anthracycline cardiomyopathy monitored by morphologic changes. Cancer Treat Rep, 62, 865–872.
  • Injac R, Strukelj B. (2008). Recent advances in protection against doxorubicin-induced toxicity. Technol Cancer Res Treat, 7, 497–516.
  • Joy PP, Thomas J, Mathew S, Skaria BP. (2001). Medicinal Plants. Tropical Horticulture Vol. 2, Naya Prokash, Calcutta, pp. 449–632.
  • Khan N, Sultana S. (2005). Chemomodulatory effect of Ficus racemosa extract against chemically induced renal carcinogenesis and oxidative damage response in Wistar rats. Life Sci, 77, 1194–1210.
  • Kirtikar KR, Basu BD. (1975). Indian Medicinal Plants. 2nd Edn, Dehra Dun, India, pp. 2327–2328.
  • Li RW, Leach DN, Myers SP, Lin GD, Leach GJ, Waterman PG. (2004). A new anti-inflammatory glucoside from Ficus racemosa L. Planta Med, 70, 421–426.
  • Lim HK, Kim HS, Choi HS, Oh S, Choi J. (2000). Hepatoprotective effects of bergenin, a major constituent of Mallotus japonicus, on carbon tetrachloride-intoxicated rats. J Ethnopharmacol, 72, 469–474.
  • Lui RC, Laregina MC, Herbold DR, Johnson FE. (1986). Testicular cytotoxicity of intravenous doxorubicin in rats. J Urol, 136, 940–943.
  • Nadkarni KM, Nadkarni AK, Chopra RN. (1976). Indian Materia Medica. Popular Prakashan, Bombay, pp. 548–550.
  • Ng R, Better N, Green MD. (2006). Anticancer agents and cardiotoxicity. Semin Oncol, 33, 2–14.
  • OECD 423. (2001). Acute oral toxicity–Acute toxic class method. OECD guidelines for testing of chemicals, 423, 1–14.
  • Priestman T. (2008). Cancer Chemotherapy in Clinical Practice. Springer-Verlag, London, UK.
  • Quiles JL, Huertas JR, Battino M, Mataix J, Ramírez-Tortosa MC. (2002). Antioxidant nutrients and adriamycin toxicity. Toxicology, 180, 79–95.
  • Rao ChV, Verma AR, Vijayakumar M, Rastogi S. (2008). Gastroprotective effect of standardized extract of Ficus glomerata fruit on experimental gastric ulcers in rats. J Ethnopharmacol, 115, 323–326.
  • Recknagel RO, Glende EA Jr, Dolak JA, Waller RL. (1989). Mechanisms of carbon tetrachloride toxicity. Pharmacol Ther, 43, 139–154.
  • Shanmugarajan TS, Arunsundar M, Somasundaram I, Krishnakumar E, Sivaraman D, Ravichandiran V. (2008). Cardioprotective effect of Ficus hispida Linn, on cyclophosphamide provoked oxidative myocardial injury in a rat model. Int J Pharmacol, 4, 78–87.
  • Singh G, Singh AT, Abraham A, Bhat B, Mukherjee A, Verma R, Agarwal SK, Jha S, Mukherjee R, Burman AC. (2008). Protective effects of Terminalia arjuna against doxorubicin-induced cardiotoxicity. J Ethnopharmacol, 117, 123–129.
  • Veerapur VP, Prabhakar KR, Parihar VK, Kandadi MR, Ramakrishana S, Mishra B, Satish Rao BS, Srinivasan KK, Priyadarsini KI, Unnikrishnan MK. (2007). Ficus racemosa stem bark extract: A potent antioxidant and a probable natural radioprotector. Evid Based Complement Alternat Med, 119, 1–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.